G-estimation of causal effects: Isolated systolic hypertension and cardiovascular death in the Framingham Heart Study

American Journal of Epidemiology

Volumn 148, Issue 4, 1998, Pages 390-401

  Witteman, Jacqueline C M ^a   D'Agostino, Ralph B ^b   Stijnen, Theo ^a   Kannel, William B ^c   Cobb, Janet C ^b   De Ridder, Maria A J ^a   Hofman, Albert ^a   Robins, James M ^d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b College of Liberal Arts ^*  (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Bias (epidemiology); Blood pressure; Cardiovascular diseases; Epidemiologic methods; Follow up studies; Models, statistical; Statistics

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; HEART DEATH; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; SYSTOLIC BLOOD PRESSURE;

EID: 0032529330     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009658     Document Type: Article

References (27)

1. Colandrea MA, Friedman GD, Nichaman MZ, et al. Systolic hypertension in the elderly. An epidemiologic assessment. Circulation 1970;XLI:239-45.
2. Fineberg MH. Systolic hypertension. Its relationship to atherosclerosis of the aorta and larger arteries. Am J Med Sci 1927;173:835-42.
3. O'Rourke M. Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension 1990; 15:339-47.
4. Kannel WB, Dawber TR, McGee DL. Perspectives on systolic hypertension. The Framingham Study. Circulation 1980;61: 1179-82.
5. Kannel WB, Wolf PA, McGee DL, et al. The Framingham Study. Systolic blood pressure, arterial rigidity, and risk of stroke. JAMA 1981;245:1225-9.
6. Safar ME, London GM. Arterial and venous compliance in sustained essential hypertension. Hypertension 1987;10: 133-9.
7. Farrar DJ, Bond MG, Sawyer JK, et al. Pulse wave velocity and morphological changes associated with early atherosclerosis progression in the aorta of cynomolgus monkeys. Cardiovasc Res 1984;18:107-18.
8. Hollander W. Role of hypertension in atherosclerosis and cardiovascular disease. Am J Cardiol 1976;38:786-800.
9. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: Wiley, 1980.
10. Robins JM. A new approach to causal inference in mortality studies with a sustained exposure period. Application to control of the healthy worker survivor effect. Math Modeling 1986;7:1393-512.
11. Robins JM, Blevins D, Ritter G, et al. G-estimation of the effect of prophylaxis therapy for Pneumocystis carinii pneumonia on the survival of AIDS patients. Epidemiology 1992; 3:319-36.
12. Robins JM, Blevins M, Ritter G, et al. Errata to "G-estimation of the effect of prophylaxis therapy for Pneumocystis carinii pneumonia on the survival of AIDS patients." Epidemiology 1993;4:189.
13. Robins JM. Estimation of the time-dependent failure time model in the presence of confounding factors. Biometrika 1992;79:321-34.
14. Robins JM. Analytic methods for HIV treatment and cofactor effects. In: Ostrow DG, Kessler R, eds. Methodologic issues of AIDS behavioral research. New York: Plenum, 1993: 213-87.
15. Mark SD, Robins JM. Estimating the causal effect of smoking cessation in the presence of confounding factors using a rank preserving structural failure time model. Stat Med 1993;12: 1605-28.
16. Robins JM, Greenland S. Adjusting for differential rates of prophylaxis therapy for PCP in high- versus low-dose AZT treatment arms in an AIDS randomized trial. J Am Stat Assoc 1994;89:737-49.
17. Robins JM. Structural nested failure time models. In: Survival analysis. In: Armitage P, Colton T, eds. Encyclopedia of biostatistics. Chichester, UK: John Wiley and Sons, 1998.
18. Cupples LA, D'Agostino RB. Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements. Framingham Heart Study, 30 year follow-up. Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes of Health, 1987: (Publication no. 87-2703).
19. Hyman JB, Epstein FH. A study of the correlation between roentgenographic and post-mortem calcification of the aorta. Am Heart J 1954;47:540-3.
20. Witteman JCM, Kok FJ, van Saase JLCM, et al. Aortic calcification as a predictor of cardiovascular mortality. Lancet 1986;2:1120-2.
21. Witteman JCM, Kannel WB, Wolf PA, et al. Aortic calcified plaques and cardiovascular disease (The Framingham Study). Am J Cardiol 1990;66:1060-4.
22. Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall, 1984.
23. Robins JM, Tsiatis AA. Correcting for non-compliance in randomized trials using a rank preserving structural failure time model. Comm Stat A 1991;20:2609-31.
24. D'Agostino RB, Lee M-L, Belanger AJ. Relation of pooled logistic regression to time-dependent Cox regression analysis: the Framingham Heart Study. Stat Med 1990;9:1501-15.
25. Groemping U. GEE: a SAS macro for longitudinal data analysis. Dortmund, Germany: Fachbereich Statistik, Universitaet Dortmund, 1993. (Arbeitsbericht no. 13).
26. Greenland S, Robins JM. Conceptual problems in the definition and interpretation of attributable fractions. Am J Epidemiol 1988;128:1185-97.
27. Hoeks APG, Brands PJ, Smeets FAM, et al. Assessment of the distensibility of superficial arteries. Ultrasound Med Biol 1990;16:121-8.